Medigus Ltd. (MDGS)
NASDAQ: MDGS
· Real-Time Price · USD
2.36
0.22 (10.28%)
At close: Apr 17, 2024, 10:00 PM
Medigus Revenue Breakdown
| Period Ending | Dec 31, 2018 | Dec 31, 2017 |
|---|---|---|
| Development Services Revenue | 217K | 161K |
| Development Services Revenue Growth | +34.78% | n/a |
| Equipments Revenue | 44K | 306K |
| Equipments Revenue Growth | -85.62% | n/a |
| Products Revenue | 175K | n/a |
| Products Revenue Growth | n/a | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|
| Europe Revenue | 19.29M | 21.9M | 1.18M | 45K |
| Europe Revenue Growth | -11.93% | +1750.97% | +2528.89% | n/a |
| Israel Revenue | 15.65M | 15.27M | 6.31M | 418K |
| Israel Revenue Growth | +2.54% | +142.05% | +1408.85% | n/a |
| United States Revenue | 49.95M | 52.13M | n/a | n/a |
| United States Revenue Growth | -4.17% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 10.14M | 5.07M | 10.69M | 5.21M | 7.75M | 7.91M | 1.92M | 640K | 1.14M | 2.33M | 577K | 645K | 881K | 649K | 786K | 1.53M | 948K | 1.34M | 1.65M | 1.87M | 1.68M | 1.4M | 1.47M | 980.85K |
| Selling, General, and Administrative Revenue Growth | +100.00% | -52.58% | +105.04% | -32.71% | -1.96% | +312.15% | +199.69% | -43.86% | -51.07% | +303.81% | -10.54% | -26.79% | +35.75% | -17.43% | -48.79% | +61.92% | -29.36% | -18.72% | -11.62% | +11.11% | +20.10% | -5.05% | +50.30% | n/a |
| Research and Development Revenue | 2.63M | 1.32M | 2.88M | 1.4M | 2.05M | 273K | 321K | 709K | 446K | 401K | 471K | 491K | 464K | 654K | 615K | 475K | 634K | 708K | 1.1M | 1.21M | 1.35M | 1.01M | 1.11M | 922.46K |
| Research and Development Revenue Growth | +100.00% | -54.25% | +105.04% | -31.46% | +649.82% | -14.95% | -54.72% | +58.97% | +11.22% | -14.86% | -4.07% | +5.82% | -29.05% | +6.34% | +29.47% | -25.08% | -10.45% | -35.81% | -8.84% | -10.53% | +34.12% | -9.36% | +20.60% | n/a |
| Sales and Marketing Revenue | 934K | 934K | 947K | 947K | 1.12M | 896K | -621K | -766K | 476K | 376K | 240K | 262K | 305K | 159K | 236K | 146K | 280K | 349K | 748K | 748K | 744.13K | 701.17K | 809.05K | 435.2K |
| Sales and Marketing Revenue Growth | 0.00% | -1.37% | 0.00% | -15.45% | +25.00% | -244.28% | -18.93% | -260.92% | +26.60% | +56.67% | -8.40% | -14.10% | +91.82% | -32.63% | +61.64% | -47.86% | -19.77% | -53.34% | 0.00% | +0.52% | +6.13% | -13.33% | +85.90% | n/a |